References
Marguerie C, Bunn CC, Copier J, Bernstein RM, Gilroy JM, Black CM, et al. The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl. Medicine (Baltimore) 1992;71:321–35.
Blaszczyk M, Jablonska S, Szymanska-Jagiello W, Jarzabek-Chorzelska M, Chorzelski T, Abdelaziz H. Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody. Pediatr Dermatol 1991;8:1–8
Hausmanowa-Petrusewicz I, Blaszczyk M, Kowalska E, Rowiñska K, Zakrzewska B, Drac H, Jablonska M. Neuromuscular studies in scleromyositis. Acta Cardiomiologica 1994;6:99–110.
Reichlin M, Maddison PJ, Targoff I, Bunch T, Arnett FC, Sharp GC, Treadwell E. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol 1984;4:40–4.
Ge Q, Wu Y, James JA, Targoff IN. Epitope analysis of the major reactive region of the 100 kD protein of PM-Scl autoantigen. Arthritis Rheum 1996;39:1588–95.
Alderuccio F, Chan EK, Tan EM. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75 kD acidic protein of the nucleolar complex. J Exp Med 1991;173:941–52.
Bluthner M, Bautz EK, Bautz FA. Mapping of epitopes recognized by PM/Scl autoantibodies with gene-fragment phage display libraries. J Immunol Methods 1996;198:187–98.
Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA Jr. Serum autoantibody to the nucleolar antigen PM-Scl: clinical and immunogenetic associations. Arthritis Rheum 1992;35:1211–7.
Schnitz W, Taylor-Albert E, Targoff IN, Reichlin M, Scofield RH. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma. J Rheumatol 1996;23:1729–33.
Alarcon-Segovia D, Cardiel MM. Comparison between three diagnostic criteria for mixed connective tissue disease: study of 593 patients. J Rheumatol 1989;16:328–34.
Amigues JM, Cantagrel A, Abbal M, Mazieres B. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol 1996;23:2055–62.
Maddison PJ, Jablonksa S. Overlap syndromes. In: Karter L, Baart de la Faille H, editors. Multi-systemic autoimmune diseases. Amsterdam: Elsevier, 1995:227–40.
Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW, Miller FW, Jarzabek-Chorzelska M, Targoff IN, et al. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997; 40:1257–66.
Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Humma M. Autoantibodies to small nuclear and cytoplasmic ribonucleo-proteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992;35:449–56.
Isern RA, Yaneva M, Weiner E, Parke A, Rothfield N, Dantzker D, et al. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med 1992;93:307–12.
Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune disease and probes for cell biology. Adv Immunol 1989;44:93–151.
Targoff IN. Laboratory manifestations of polymyositis/dermatomyositis. Clin Dermatol 1988;6:76–92.
Targoff IN. Autoantibodies in polymyositis. Rheum Dis Clin North Am 1992;18:455–82.
Love LA, Miller FW. Noninfectious environmental agents associated with myopathies. Curr Opin Rheumatol 1993;5:712–8.
Hausmanova-Petrusewicz I, Blaszczyk M, Jablonska S. Coexistence of scleromyositis associated with PM-Scl antibody and myasthenia. Neuromusc Disord 1995;5:145–7.
Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993;100:116S-23S.
Miller FW. Myositis specific autoantibodies: touchstones for understanding the inflammatory myopathies. JAMA 1993;270:1846–9.
Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 1991;70:360–74.
Jablonska S, Chorzelski TP, Blaszczyk M, Jarzabek-Chorzelska M, Kumar V, Beutner EH. Scleroderma/polymyositis overlap syndromes and their immunologic markers. Clin Dermatol 1993;10:457–72.
Engel AG, Hohlfeld R, Banker BQ. The polymyositis and dermatomyositis syndromes. In: Engel AG, Banker BQ, editors. Myology. New York: McGraw-Hill, 1994.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jablonska, S., Blaszcyk, M. Scleromyositis: a scleroderma/polymyositis overlap syndrome. Clin Rheumatol 17, 465–467 (1998). https://doi.org/10.1007/BF01451281
Issue Date:
DOI: https://doi.org/10.1007/BF01451281